About the event
ESGCT is an annual scientific meeting that brings together researchers and clinicians in the field of gene and cell therapy to share their latest findings, discuss new ideas, and collaborate on future projects. The convention covers a wide range of topics related to gene and cell therapy, including new technologies, clinical trials, and regulatory issues.
Bioanalytical Experts for Advanced Therapeutic Medicinal Products
As the gene and cell therapy space continues to grow and new regulations are implemented by global agencies, finding CRO partners with the appropriate expertise and capabilities to support these preclinical and clinical programs is a critical component of success. Our scientific experts are thought leaders in the field with decades of combined experience across a wide range of gene and cell therapy products.
Since 2014, BioAgilytix has supported almost 300 unique gene therapy programs for more than 100 different sponsors and has partnered with our clients to support bioanalytical testing for over 80 individual cell therapy programs, including two that have received FDA-approval.
Our scientific teams are experienced across an array of platforms and assay types with the ability to work under nonregulated, GMP, GLP, GCP/GCLP, and CLIA conditions to meet your program needs. Common assays include:
- Biodistribution (qPCR or ddPCR)
- Persistence (qPCR, ddPCR, flow cytometry)
- Vector Shedding (qPCR or ddPCR)
- Total Antibody or Anti-Drug Antibody Assays (TAb or ADA)
- Neutralizing Antibody Assays (NAb)
- Cellular Immunogenicity (ELISpot)
- Custom Biomarker Solutions
- Product Release Testing (CMC)